共 291 条
[1]
Xu C(2015)Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds J Hepatol 62 1412-1419
[2]
Wan X(2017)Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: an observational study Medicine (Baltimore) 96 e8164-366
[3]
Xu L(2020)Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity Ann Hepatol 19 359-e185
[4]
Weng H(2022)Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association Arterioscler Thromb Vasc Biol 42 e168-1326
[5]
Yan M(2022)Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors Hypertension 79 1319-472
[6]
Miao M(2022)Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke Diabetes Obes Metab 24 465-344
[7]
Sun Y(2017)Nonalcoholic fatty liver disease and insulin resistance new insights and potential new treatments Nutrients 10 330-1151
[8]
Xu G(2013)Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 56 1145-427
[9]
Dooley S(2012)Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up J Hepatol 16 421-1140
[10]
Li Y(2005)Nonalcoholic fatty liver disease and the metabolic syndrome Curr Opin Lipidol 111 1133-254